| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 06/05/1997 | WO1997020050A1 Therapeutic and diagnostic compositions |
| 06/05/1997 | WO1997019940A1 Furan- and thiophenecarbothioamide derivatives, their preparation and their use as inhibitors of the replication of hiv-1 and hiv-1 mutants |
| 06/05/1997 | WO1997019702A2 Powdery iodine complexes |
| 06/05/1997 | WO1997019688A1 Non-toxic mutants of pathogenic gram-negative bacteria |
| 06/05/1997 | WO1997019681A1 Perfluoroalkyl substituted metallo-beta-lactamase inhibitors and method for the preparation of trifluoromethylketone derivatives |
| 06/05/1997 | WO1997019593A1 Antimicrobial composition and methods of use therefor |
| 06/05/1997 | WO1997013772A3 Cephalosporin antibiotics |
| 06/05/1997 | DE19544449A1 Pulverförmige Iod-Komplexe Powdered iodine complexes |
| 06/05/1997 | CA2238484A1 Antimicrobial composition and methods of use therefor |
| 06/05/1997 | CA2236574A1 Therapeutic and diagnostic compositions |
| 06/05/1997 | CA2191835A1 Use of 8,9-dehydroestrone as an antioxidant |
| 06/04/1997 | EP0776885A1 Diaromatic compounds with an adamantyl group in the ortho position, pharmaceutical and cosmetic compositions containing them and uses |
| 06/04/1997 | EP0776881A1 Bi-aromatic compounds comprising an adamantyl group in para-position, pharmaceutical and cosmetic compositions containing them and their utilization |
| 06/04/1997 | EP0776366A1 Chimeric proteins and muteins of tissue factor pathway inhibitors tfpi and tfpi-2 |
| 06/04/1997 | EP0776362A1 Method for preparing an influenza virus, antigens obtained and applications thereof |
| 06/04/1997 | EP0776336A1 Vitronectin binding protein |
| 06/04/1997 | EP0776331A1 Higher order structure and binding of peptide nucleic acids |
| 06/04/1997 | EP0776214A1 Antibacterial composition containing multimeric alpha-lactalbumin |
| 06/04/1997 | EP0776209A1 Polynucleic acids and proteins from a porcine reproductive and respiratory syndrome virus and uses thereof |
| 06/04/1997 | EP0776205A1 Pharmaceutical formulation |
| 06/04/1997 | EP0691980B1 7-deazapurine modified oligonucleotides |
| 06/04/1997 | CN1151185A Nucleotide sequences of pestivirus strains, polypeptides encoded by these squences and use thereof for diagnosis and prevention of pestivirus infections |
| 06/04/1997 | CN1151119A Medical use of bromelain |
| 06/04/1997 | CN1151116A Pharmaceutical compositions comprising an opiate antagonist and calcium salts, their use for the treatment of endorphin-mediated pathologies |
| 06/04/1997 | CN1150950A Cephalosporin derivatives |
| 06/04/1997 | CN1035056C Method for preparing cyclic neurokinin A antagonists |
| 06/04/1997 | CN1035039C Preparation method for dimethylamine tetracycline drug transmission system |
| 06/04/1997 | CN1035038C Preparation of pharmaceutical composition for preventing venereal disease |
| 06/03/1997 | US5635501 Alphalosporins and 1-carba-1-dethia cephalosporins |
| 06/03/1997 | US5635485 Erythromycin compounds |
| 06/03/1997 | US5635185 Extracts of Piliostigma thonningii, the use thereof and formulations containing them |
| 06/03/1997 | US5635181 Pure immunogenic peptide encoded by dna sequence present in specified recombinant bacterial plasmid |
| 06/03/1997 | CA2143204C Use of dideoxy nucleoside analogues in the treatment of viral infections |
| 06/03/1997 | CA2077651C Peptides stimulating cytotoxic t cells immune to hiv rt |
| 05/29/1997 | WO1997019174A1 Virus protein antigens of the jc virus |
| 05/29/1997 | WO1997019113A2 Monoclonal antiidiotypic antibodies (ab2) and uses thereof |
| 05/29/1997 | WO1997019107A1 Identification of antigenes from post-infection nematodes for the purpose of developing new anthelmintics and vaccines |
| 05/29/1997 | WO1997019104A1 Cyclopeptolides |
| 05/29/1997 | WO1997019089A1 Oxazolidinone antibacterial agent with tricyclic substituents |
| 05/29/1997 | WO1997019081A1 Synthetic metal-substituted bacteriochlorophyll derivatives and use thereof |
| 05/29/1997 | WO1997019055A1 Azahexane derivatives as substrate isosters of retroviral asparate proteases |
| 05/29/1997 | WO1997018837A1 Novel non-pyrogenic bacterial strains and use of the same |
| 05/29/1997 | WO1997018836A1 Virus replication inhibitor |
| 05/29/1997 | WO1997018827A1 Compositions and methods for the prevention and treatment of oral mucositis |
| 05/29/1997 | WO1997018826A1 Fine tuned protegrins |
| 05/29/1997 | WO1997018813A1 Inhibitors of farnesyl-protein transferase |
| 05/29/1997 | WO1997013505A3 USE OF A η-RAR-SPECIFIC AGONIST LIGAND TO INCREASE APOPTOSIS RATE |
| 05/29/1997 | CA2238081A1 Inhibitors of farnesyl-protein transferase |
| 05/29/1997 | CA2237016A1 Azahexane derivatives as substrate isosters of retroviral asparate proteases |
| 05/29/1997 | CA2210705A1 Monoclonal antiidiotypic antibodies (ab2) and their uses |
| 05/28/1997 | EP0775743A2 Sustainable chick cell line infected with Marek's disease virus |
| 05/28/1997 | EP0775486A1 Antibacterial, antimycotic and antviral compositions based on alpha-hydroxyalkanoic acids and squalene |
| 05/28/1997 | EP0775478A1 Combinations of active ingredients based on partial glycerides and dialkylsubstituted acetic acids efficient against bacteria, mycoses and viruses |
| 05/28/1997 | EP0775209A1 Identification of a human cytomegalovirus gene region involved in down-regulation of mhc class i heavy chain expression |
| 05/28/1997 | EP0775202A1 Human interleukin variants generated by alternative splicing |
| 05/28/1997 | EP0775158A1 Organic compounds |
| 05/28/1997 | EP0775151A2 Sialic acid/fucose based medicaments |
| 05/28/1997 | EP0775145A1 Process for making quinolonyl lactam antimicrobials and novel intermediate compounds |
| 05/28/1997 | EP0775144A1 6 beta-substituted penicillanic acids as beta-lactamase inhibitors |
| 05/28/1997 | EP0775130A1 Method for the preparation of (+/-)-calanolide a and intermediates thereof |
| 05/28/1997 | EP0775122A1 Crystalline form of an antifungal azole |
| 05/28/1997 | EP0775118A1 Benzimidazole derivatives having dopaminergic activity |
| 05/28/1997 | EP0775115A1 Dimeric arylisoquinoline alkaloids and synthesis methods thereof |
| 05/28/1997 | EP0775114A1 Process for making antimicrobial compounds |
| 05/28/1997 | EP0775110A1 Arylthio compounds as antibacterial and antiviral agents |
| 05/28/1997 | EP0774971A1 Synthetic peptide inhibitors of hiv transmission |
| 05/28/1997 | EP0774969A1 Hiv protease inhibitor combination |
| 05/28/1997 | EP0774902A1 Antisense and triplex therapeutic agents and methods |
| 05/28/1997 | EP0671918B1 Compositions containing acyclovir-like compounds and 2'-vinyl substituted nucleoside analogs for the treatment of viral infections |
| 05/28/1997 | EP0571420B1 Mycobacterium polypeptides and nucleic acids encoding them for diagnosis and control of tuberculosis |
| 05/28/1997 | EP0546092B1 Therapeutic ribozyme compositions |
| 05/28/1997 | EP0512112B1 Anti cd-4 antibodies blocking hiv-induced syncytia |
| 05/28/1997 | DE19543554A1 Identifizierung von Antigenen aus post-infektiösen Nematoden zur Entwicklung neuer Anthelmintika und Vakzinen Identification of antigens from post-infective nematodes to develop new vaccines and anthelmintics |
| 05/28/1997 | DE19543553A1 VP-Antigene des JC-Virus VP-antigens of the JC virus |
| 05/28/1997 | CN1150819A Vaccine against mumps containing jeryl-Lynn virus strain |
| 05/28/1997 | CN1150803A Pyrazolo and pyrrolopyridines |
| 05/28/1997 | CN1150589A New sulfuric acid esters of sugar alcohols |
| 05/28/1997 | CN1150547A External use emulsion for curing burn |
| 05/27/1997 | US5633366 Chemical intermediates for 3'-azido-3'-deoxythymidine |
| 05/27/1997 | US5633346 Cyclization, fungicides |
| 05/27/1997 | US5633345 Cyclic peptides |
| 05/27/1997 | US5633280 Urethanes and ureas that induce cytokine production |
| 05/27/1997 | US5633262 Quinoline carboxylic acid derivatives having 7-(4-amino-methyl-3-oxime) pyrrolidine substituent and processes for preparing thereof |
| 05/27/1997 | US5633231 Cytomegalovirus |
| 05/27/1997 | US5633015 Drug dosage units |
| 05/27/1997 | US5633006 Oxide of a group 2a metal |
| 05/27/1997 | US5632989 Screening with a monoclonal antibodies |
| 05/27/1997 | US5632980 AIDS therapeutic agents comprising polymers formed from cinnamic acid derivatives |
| 05/27/1997 | CA2131185C Substituted pipecolinic acid derivatives as hiv protease inhibitors |
| 05/22/1997 | WO1997018312A1 Chimeric oligomers having an rna-cleavage activity |
| 05/22/1997 | WO1997018309A1 E6 binding proteins |
| 05/22/1997 | WO1997018237A1 Chemokine from niddm pancreas |
| 05/22/1997 | WO1997018214A1 Hemoregulatory compounds |
| 05/22/1997 | WO1997018213A1 Hemoregulatory compounds |
| 05/22/1997 | WO1997018210A1 Hemoregulatory compounds |
| 05/22/1997 | WO1997018205A1 Substituted sulfonylalkanoylamino hydroxyethylamino sulfonamide retroviral protease inhibitors |
| 05/22/1997 | WO1997017985A1 Hemoregulatory compounds |
| 05/22/1997 | WO1997017983A1 Methods of treating disorders of non-visual sensory epithelia |
| 05/22/1997 | WO1997017981A1 Anti-viral isolates obtainable from leeches |
| 05/22/1997 | WO1997017973A1 Hemoregulatory compounds |